CA2230284A1 - Reactifs de pretraitement et procedes associes - Google Patents
Reactifs de pretraitement et procedes associes Download PDFInfo
- Publication number
- CA2230284A1 CA2230284A1 CA 2230284 CA2230284A CA2230284A1 CA 2230284 A1 CA2230284 A1 CA 2230284A1 CA 2230284 CA2230284 CA 2230284 CA 2230284 A CA2230284 A CA 2230284A CA 2230284 A1 CA2230284 A1 CA 2230284A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- assay
- sample
- amount
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
- G02B6/24—Coupling light guides
- G02B6/42—Coupling light guides with opto-electronic elements
- G02B6/4201—Packages, e.g. shape, construction, internal or external details
- G02B6/4248—Feed-through connections for the hermetical passage of fibres through a package wall
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9493—Immunosupressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cephalosporin Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
L'invention concerne des compositions et des kits destinés au prétraitement d'échantillons devant être analysés afin de déterminer la présence et/ou la quantité d'une substance à analyser. La composition comprend un alcool d'alkyle inférieur, dans une proportion d'environ 30 à 40 % en volume, un glycol, dans une proportion d'environ 20 à 40 % en volume, et un composant aqueux comprenant environ 20 à 30 mM de sel de cuivre. En outre, le composant aqueux peut comprendre environ 0,5 à 20 mM d'un tampon, et environ 0,005 à 0,2 % en poids d'un détergent non ionique et présente un pH d'environ 2,0 à environ 4,6. Les kits comprennent également un ou plusieurs réactifs destinés à la réalisation d'un dosage pour la substance à analyser associée. L'invention concerne également des améliorations apportées à des dosages destinés à des substances à analyser associées, lesdites améliorations comprenant le prétraitement d'un échantillon supposé contenir la substance à analyser avec la composition ci-dessus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2120196P | 1996-07-03 | 1996-07-03 | |
US60/021,201 | 1996-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2230284A1 true CA2230284A1 (fr) | 1998-01-08 |
Family
ID=21802919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2230284 Abandoned CA2230284A1 (fr) | 1996-07-03 | 1997-07-03 | Reactifs de pretraitement et procedes associes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0850402A4 (fr) |
JP (1) | JP2001514737A (fr) |
AU (1) | AU3730097A (fr) |
CA (1) | CA2230284A1 (fr) |
WO (1) | WO1998000696A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7575875B2 (en) * | 2005-10-13 | 2009-08-18 | Abbott Laboratories, Inc. | Method of tacrolimus extraction and quantification using aqueous detergents |
US7256008B2 (en) | 2006-01-06 | 2007-08-14 | Abbott Laboratories | Determination of concentration of FK778 by competitive immunoassay |
US7883855B2 (en) | 2006-07-21 | 2011-02-08 | Abbott Laboratories | Immunosuppressant drug extraction reagent for immunoassays |
WO2008082984A2 (fr) | 2006-12-29 | 2008-07-10 | Abbott Laboratories | Réactif de lyse non dénaturante destiné à être utilisé en immunoessai de capture en solution |
WO2008082982A1 (fr) * | 2006-12-29 | 2008-07-10 | Abbott Laboratories | Dosage amélioré de médicaments immunosuppresseurs |
US7914999B2 (en) | 2006-12-29 | 2011-03-29 | Abbott Laboratories | Non-denaturing lysis reagent |
EP2118654B1 (fr) | 2006-12-29 | 2013-03-27 | Abbott Laboratories | Dosage diagnostique pour la detection d'une molecule ou d'un medicament dans du sang total |
US7790401B2 (en) * | 2007-08-06 | 2010-09-07 | Siemens Healthcare Diagnostics | Methods for detection of immunosuppressant drugs |
US20210285975A1 (en) * | 2017-12-25 | 2021-09-16 | Fujirebio Inc. | Method of testing a blood for macrolide immunosuppressant |
EP3851850A4 (fr) * | 2018-09-12 | 2022-06-08 | Sekisui Medical Co., Ltd. | Réactif et procédé de mesure d'hémoglobines |
US20210278422A1 (en) | 2018-09-12 | 2021-09-09 | Sekisui Medical Co., Ltd. | Reagent and method for measuring hemoglobins |
CN114964939B (zh) * | 2021-12-20 | 2024-09-13 | 上海云泽生物科技有限公司 | 一种药物-蛋白解离组合物、含其的环孢霉素检测试剂盒及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1401380A1 (ru) * | 1986-03-20 | 1988-06-07 | Горьковский политехнический институт им.А.А.Жданова | Способ количественного определени истинного белка в кормовых дрожжах |
JP2684069B2 (ja) * | 1988-10-13 | 1997-12-03 | 昇一 首藤 | 免疫学的活性物質の測定方法及びそのための試薬 |
WO1991013357A1 (fr) * | 1990-02-28 | 1991-09-05 | Takeda Chemical Industries, Ltd. | Analyse immunologique amelioree |
US5135875A (en) * | 1990-08-15 | 1992-08-04 | Abbott Laboratories | Protein precipitation reagent |
CA2048302A1 (fr) * | 1990-08-15 | 1992-02-16 | Victoria P. Meucci | Reactif de solubilisation des echantillons dans des epreuves biologiques |
JPH07315803A (ja) * | 1994-05-26 | 1995-12-05 | Otsuka Chem Co Ltd | 金属塩化物溶液及び金属塩化物の安定化方法 |
-
1997
- 1997-07-03 JP JP50451998A patent/JP2001514737A/ja active Pending
- 1997-07-03 CA CA 2230284 patent/CA2230284A1/fr not_active Abandoned
- 1997-07-03 EP EP97934184A patent/EP0850402A4/fr not_active Withdrawn
- 1997-07-03 AU AU37300/97A patent/AU3730097A/en not_active Abandoned
- 1997-07-03 WO PCT/US1997/012420 patent/WO1998000696A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0850402A4 (fr) | 1998-12-09 |
JP2001514737A (ja) | 2001-09-11 |
WO1998000696A1 (fr) | 1998-01-08 |
EP0850402A1 (fr) | 1998-07-01 |
AU3730097A (en) | 1998-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7790401B2 (en) | Methods for detection of immunosuppressant drugs | |
EP2217926B1 (fr) | Procédés de détection de médicaments hydrophobes | |
EP0487301B1 (fr) | Procédé pour la stabilisation des enzymes-conjugués | |
CA2230284A1 (fr) | Reactifs de pretraitement et procedes associes | |
EP3368900B1 (fr) | Dosage en sandwich pour petites molécules | |
US12111310B2 (en) | Pretreatment agent in non-agglutination assays | |
US20110318754A1 (en) | Reduction in False Results in Assay Measurements | |
US20090258435A1 (en) | Biotin-receptor reagents for sensitivity modulation in assays | |
KR101962252B1 (ko) | 전체 분석물 농도의 결정 | |
EP0970107B1 (fr) | Derives de cyclosporine et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |